Stay updated on Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated the website revision indicator in the page footer from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-26T15:42:44.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T14:14:00.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added the iRECIST guidelines citation (Lancet Oncology, 2017) to the Publications section and removed the associated erratum notice (Lancet Oncology, 2019).
    Difference
    0.1%
    Check dated 2026-04-05T06:59:49.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-21T20:00:03.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Updated iRECIST guideline reference to the 3.4.3 revision (including the erratum) and removed the older 3.4.2 citation.
    Difference
    0.1%
    Check dated 2026-03-07T08:40:14.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-02-14T05:16:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.